Back to JHPCYView full pipeline
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
Upcoming Catalysts
What are catalysts?Competitive Landscape
0 competitors in Local Analgesia Via Nerve Block
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Regulatory Approvals
EMA11/16/2020
Exparel liposomal
Exparel liposomal is indicated: in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain. in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.
View on EMADrug Science
Mechanism of action & safety profile
Related Pipeline
apatinibPhase 3
Non-Small-Cell Lung Cancer
SHR6390Phase 3
Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage，Female Breast Cancer
PyrotinibPhase 3
HER2-positive Breast Cancer
SHR-1209Phase 3
Primary Hypercholesterolemia
SHR-1210Phase 3
Nasopharyngeal Carcinoma
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts